# Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/definition-incidence-and-challenges-for-assessment-of-hyperprogressive-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hyo Jung Park,Kyung Won Kim,Sang Eun Won,Shinkyo Yoon,Young Kwang Chae,Sree Harsha Tirumani,Nikhil H. Ramaiya |
| Citations | 97 |
| DOI | 10.1001/jamanetworkopen.2021.1136 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2777859/park_2021_oi_210058_1616042439.44316.pdf |
| OpenAlex ID | https://openalex.org/W3137983189 |
| PMID | 33760090 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Shinkyo Yoon](https://scholariq.org/researchers/shinkyo-yoon/)

## Paper journal

- [JAMA Network Open](https://scholariq.org/journals/jama-network-open/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Multiple and Secondary Primary Cancers](https://scholariq.org/topics/multiple-and-secondary-primary-cancers/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.